Apparatuses and methods for storing pharmaceutical product

A method of managing use of pharmaceutical product, comprising the steps of:

• activating each of first and second access components of a pharmaceutical product container when said pharmaceutical product container is in a closed configuration, wherein said first and second access components are disposed in non-opposing relation to one another, and wherein said pharmaceutical product container is locked when in said closed configuration;
• unlocking said pharmaceutical product container using said activating step in relation to each of said first and second access components;
• changing said pharmaceutical product container into an open configuration after said unlocking step;
• changing said pharmaceutical product container into said closed configuration;
• and
• disabling said first access component such that said first access component is thereafter unavailable for any subsequent execution of said unlocking step, wherein said disabling step comprises heating said pharmaceutical product container to a temperature such that any subsequent activation of said first access component will not be usable for any subsequent said unlocking step, and wherein said temperature is less than a melting temperature of a container body of said pharmaceutical product container.

A method of managing use of pharmaceutical product, comprising the steps of:

• activating each of first and second access components of a pharmaceutical product container when said pharmaceutical product container is locked in a closed configuration, wherein said first and second access components are disposed in non-opposing relation to one another for execution of said activating;
• unlocking said pharmaceutical product container using said activating in relation to each of said first and second access components;
• opening said pharmaceutical product container by changing said pharmaceutical product container from said closed configuration to an open configuration, wherein said opening is executed after said unlocking;
• closing said pharmaceutical product container by changing said pharmaceutical product container from said open configuration back to said closed configuration;
• locking said pharmaceutical product container after said closing to retain said pharmaceutical product container in said closed configuration;
• and
• disabling said first access component after said locking such that said first access component is thereafter unavailable for any subsequent execution of said unlocking whereby said pharmaceutical product container thereafter remains locked in said closed configuration.